Table 2 Treatment outcomes and early adverse events of EGBS
Outcomes | n = 49 |
|---|---|
Clinical success | 46 (97%) |
EGBS-related adverse events | |
Cystic duct injury | 3 (6%) |
Bile peritonitis | 0 (0%) |
ERCP-related adverse events | |
Bleeding | 0 (0%) |
Perforation | 0 (0%) |
Pancreatitis | 2 (4%) |
Cholangitis | 0 (0%) |
Severity of ERCP-related adverse events | |
Mild | 2 (100%) |
Moderate | 0 (0%) |
Severe | 0 (0%) |